Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. TB is a major public health and financial issue
3. TB control is highly cost-effective
4. Presentation overview
5. Patterns & trends in global TB control financing
6. Funding available by intervention
7. Funding available by location
8. Funding available by source
9. Donor funding for TB and other programmes
10. Domestic funding across countries
11. Counterpart financing
12. Cost per patient treated, US dollars
13. Value for money
14. Global financing needs: The Global Plan
15. DOTS expansion and enhancement, DR-TB
16. Funding needed to meet the global targets
17. The funding gap
18. Funding required - funding available
19. Closing the funding gap
20. Patient perspective
21. Cost faced by patients before TB treatment
22. Costs prior to TB diagnosis
23. Costs during TB treatment
24. Multi drug resistance TB financial cost
25. Share of costs faced by patients during treatment
26. MDR-TB patient experience - interview
27. Some references
28. Main messages
29. Thank you

Topics Covered

• Cost-effectiveness of TB control interventions
• Patterns and trends in global TB control financing from the health system perspective
• Financing needs for global TB control from the health system perspective
• Costs faced by patients in seeking treatment for TB

Links

Series:

• Tuberculosis

Categories:

• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Respiratory Diseases

Talk Citation

Publication History

• Published on March 3, 2013

Financial Disclosures

• Dr. Christopher Fitzpatrick has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
• Dr. Andrea Pantoja has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.